Histologic validation of locus coeruleus MRI contrast in post-mortem tissue

NeuroImage

Volumn 113, Issue , 2015, Pages 235-245

  Keren, Noam I ^a   Taheri, Saeid ^a   Vazey, Elena M ^a   Morgan, Paul S ^a   Granholm, Ann Charlotte E ^a   Aston Jones, Gary S ^a   Eckert, Mark A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Brainstem; Histology; Inversion recovery; MRI; Neuromelanin; Norepinephrine; Post mortem

Indexed keywords

NEUROMELANIN; NORADRENALIN; TYROSINE 3 MONOOXYGENASE; BIOLOGICAL MARKER; COLORING AGENT; MELANIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN ASYMMETRY; BRAIN RADIOGRAPHY; BRAIN SLICE; CLINICAL ARTICLE; DIFFUSE LEWY BODY DISEASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOCUS CERULEUS; MALE; MICROSCOPY; MIDDLE AGED; NEUROFIBRILLARY TANGLE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; VERY ELDERLY; ANATOMY AND HISTOLOGY; BRAIN STEM; CADAVER; ENZYMOLOGY; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; METABOLISM; POSTMORTEM CHANGE; REPRODUCIBILITY;

AGED; AGED, 80 AND OVER; BIOMARKERS; BRAIN STEM; CADAVER; COLORING AGENTS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; LOCUS COERULEUS; MAGNETIC RESONANCE IMAGING; MALE; MELANINS; MIDDLE AGED; POSTMORTEM CHANGES; REPRODUCIBILITY OF RESULTS; TYROSINE 3-MONOOXYGENASE;

EID: 84926157801     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2015.03.020     Document Type: Article

References (59)

1. Allen T.C. Hematoxylin and eosin. Laboratory Methods in Histotechnology 1992, 53-58. American Registry of Pathology, Washington, DC. 1st ed. E.B. Prohpet, B. Mills, J.B. Arrington, L.H. Sobin (Eds.).
2. Aston-Jones G., Cohen J.D. Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance. J. Comp. Neurol. 2005, 493:99-110.
3. Aston-Jones G., Foote S.L., Bloom F. Anatomy and physiology of locus coeruleus neurons: functional implications. Norepinephrine (Frontiers of Clinical Neuroscience) 1984, Vol. 2:92-116. Williams and Wilkins Co, Baltimore. C.R.L. Ziegler (Ed.).
4. Aston-Jones G., Rajkowski J., Cohen J. Locus coeruleus and regulation of behavioral flexibility and attention. Prog. Brain Res. 2000, 126:165-182.
5. Baker K.G., Halliday G.M., Hornung J.P., Geffen L.B., Cotton R.G., Törk I. Distribution, morphology and number of monoamine-synthesizing and substance P-containing neurons in the human dorsal raphe nucleus. Neuroscience 1991, 42(3):757-775.
6. Benveniste H., Blackband S. MR microscopy and high resolution small animal MRI: applications in neuroscience research. Prog. Neurobiol. 2002, 67:393-420.
7. Bloembergen N., Purcell E., Pound R. Relaxation effects in nuclear magnetic resonance absorption. Phys. Rev. 1948, 73:679-712.
8. Bolding M.S., Reid M.A., Avsar K.B., Roberts R.C., Gamlin P.D., Gawne T.J., White D.M., den Hollander J.A., Lahti A.C. Magnetic transfer contrast accurately localizes substantia nigra confirmed by histology. Biol. psychiatry 2013, 73(3):289-294.
9. Braak H., Rüb U., Sandmann-Keil D., Gai W.P., de Vos R.A.I., Jansen Steur E.N.H., Arai K., Braak E. Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system. Acta Neuropathol. 2000, 99:489-495.
10. Buchman A.S., Nag S., Shulman J.M., Lim A.S., VanderHorst V.G., Leurgans S.E., Schneider J.A., Bennett D.A. Locus coeruleus neuron density and parkinsonism in older adults without Parkinson's disease. Mov. Disord. 2012, 27(13):1625-1631.
11. Carli M., Robbins T.W., Evenden J.L., Everitt B.J. Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav. Brain Res. 1983, 9(3):361-380.
12. Chan-Palay V. Alterations in the locus coeruleus in dementias of Alzheimer's and Parkinson's disease. Prog. Brain Res. 1991, 88:625-630.
13. Chan-Palay V., Asan E. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression. J. Comp. Neurol. 1989, 287:373-392.
14. Chan-Palay V., Asan E. Quantitation of catecholamine neurons in the locus coeruleus in human brains of normal young and older adults and in depression. J. Comp. Neurol. 1989, 287:357-372.
15. Chen J., Daniel B.L., Pauly K.B. Investigation of proton density for measuring tissue temperature. J. Magn. Reson. Imaging 2006, 23:430-434.
16. Chen X., Huddleston D.E., Langley J., Ahn S., Barnum C.J., Factor S.A., Levey A.I., Hu X. Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach. Magn. Reson. Imaging 2014, 32:1301-1306.
17. De Poorter J. Noninvasive MRI thermometry with the proton resonance frequency method: study of susceptibility effects. Magn. Reson. Med. 1995, 34:359-367.
18. Dixon W.T., Engels H., Castillo M., Sardashti M. Incidental magnetization transfer contrast in standard multislice imaging. Magn. reson. imaging 1990, 8(4):417-422.
19. Fedorow H., Halliday G.M., Rickert C.H., Gerlach M., Riederer P., Double K.L. Evidence for specific phases in the development of human neuromelanin. Neurobiol. Aging 2006, 27(3):506-512.
20. Frieden I.J., Williams M.L., Barkovich A.J. Giant congenital melanocytic nevi: brain magnetic resonance findings in neurologically asymptomatic children. J. Am. Acad. Dermatol. 1994, 31:423-429.
21. German D.C., Walker B.S., Manaye K., Smith W.K., Woodward D.J., North A.J. The human locus coeruleus: computer reconstruction of cellular distribution. J. Neurosci. 1988, 8:1776-1788.
22. German D.C., Manaye K.F., White C.L., Woodward D.J., McIntire D.D., Smith W.K., Kalaria R.N., Mann D.M. Disease-specific patterns of locus coeruleus cell loss. Ann. Neurol. 1992, 32:667-676.
23. Grudzien A., Shaw P., Weintraub S., Bigio E., Mash D.C., Mesulam M.M. Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease. Neurobiol. Aging 2007, 28:327-335.
24. Halliday G.M., Fedorow H., Rickert C.H., Gerlach M., Riederer P., Double K.L. Evidence for specific phases in the development of human neuromelanin. J. Neural Transm. 2006, 113:721-728.
25. Hampel H., Frank R., Broich K., Teipel S.J., Katz R.G., Hardy J., Herholz K., Bokde A.L., Jessen F., Hoessler Y.C., Sanhai W.R., Zetterberg H., Woodcock J., Blennow K. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Nat. Rev. Drug Discov. 2010, 9(7):560-574.
26. Jack C.R., Knopman D.S., Weigand S.D., Wiste H.J., Vemuri P., Lowe V., Kantarci K., Gunter J.L., Senjem M.L., Ivnik R.J., Roberts R.O., Rocca W.A., Boeve B.F., Petersen R.C. An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Ann. Neurol. 2012, 71(6):765-775.
27. Johnson G.A., Benveniste H., Black R.D., Hedlund L.W., Maronpot R.R., Smith B.R. Histology by magnetic resonance microscopy. Magn. Reson. Q. 1993, 9:1-30.
28. Jouvet M. Biogenic amines and the states of sleep. Science 1969, 163(3862):32-41.
29. Ju K.Y., Lee J.W., Im G.H., Lee S., Pyo J., Park S.B., Lee J.H., Lee J.K. Bio-inspired, melanin-like nanoparticles as a highly efficient contrast agent for T1-weighted magnetic resonance imaging. Biomacromolecules 2013, 14:3491-3497.
30. Keren N.I., Lozar C.T., Harris K.C., Morgan P.S., Eckert M.A. In vivo mapping of the human locus coeruleus. NeuroImage 2009, 47:1261-1267.
31. Kitao S., Matsusue E., Fujii S., Miyoshi F., Kaminou T., Kato S., Ito H., Ogawa T. Correlation between pathology and neuromelanin MR imaging in Parkinson's disease and dementia with Lewy bodies. Neuroradiology 2013, 55(8):947-953.
32. Koral K., Derinkuyu B., Timmons C., Schwartz-Dabney C.L., Swift D. Melanotic neuroectodermal tumor of infancy: report of one calvarial lesion with T1 shortening and one maxillary lesion. Clin. Imaging 2010, 34:382-384.
33. Manaye K.F., McIntire D.D., Mann D.M., German D.C. Locus coeruleus cell loss in the aging human brain: a non-random process. J. Comp. Neurol. 1995, 358:79-87.
34. Mann D., Yates P. Possible role of neuromelanin in the pathogenesis of Parkinson's disease. Mech. Ageing Dev. 1983, 21:193-203.
35. Matsuura K., Maeda M., Yata K., Ichiba Y., Yamaguchi T., Kanamaru K., Tomimoto H. Neuromelanin magnetic resonance imaging in Parkinson's disease and multiple system atrophy. Eur. Neurol. 2013, 70:70-77.
36. Morecraft R.J., Geula C., Mesulam M.M. Cytoarchitecture and neural afferents of orbitofrontal cortex in the brain of the monkey. J. Comp. Neurol. 1992, 323:341-358.
37. Morrison J.H., Foote S.L. Noradrenergic and serotoninergic innervation of cortical, thalamic, and tectal visual structures in Old and New World monkeys. J. Comp. Neurol. 1986, 243:117-138.
38. Morrison J.H., Foote S.L., O'Connor D., Bloom F.E. Laminar, tangential and regional organization of the noradrenergic innervation of monkey cortex: dopamine-beta-hydroxylase immunohistochemistry. Brain Res. Bull. 1982, 9:309-319.
39. Nakane T., Nihashi T., Kawai H., Naganawa S. Visualization of neuromelanin in the substantia nigra and locus ceruleus at 1.5T using a 3D-gradient echo sequence with magnetization transfer contrast. Magn. Reson. Med. 2008, 7(4):205-210.
40. Ohtsuka C., Sasaki M., Konno K., Koide M., Kato K., Takahashi J., Takahashi S., Kudo K., Yamashita F., Terayama Y. Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging. Neurosci. Lett. 2013, 541:93-98.
41. Pfefferbaum A., Sullivan E.V., Adalsteinsson E., Garrick T., Harper C. Postmortem MR imaging of formalin-fixed human brain. NeuroImage 2004, 21:1585-1595.
42. Porrino L.J., Goldman-Rakic P.S. Brainstem innervation of prefrontal and anterior cingulate cortex in the rhesus monkey revealed by retrograde transport of HRP. J. Comp. Neurol. 1982, 205:63-76.
43. Premkumar A., Marincola F., Taubenberger J., Chow C., Venzon D., Schwartzentruber D. Metastatic melanoma: correlation of MRI characteristics and histopathology. J. Magn. Reson. Imaging 1996, 6:190-194.
44. Rochat L., Billieux J., Juillerat Van der Linden A.C., Annoni J.M., Zekry D., Gold G., Van der Linden M. A multidimensional approach to impulsivity changes in mild Alzheimer's disease and control participants: cognitive correlates. Cortex 2013, 49(1):90-100.
45. Salmon D.P. Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease. Curr. Top. Behav. Neurosci. 2012, 10:187-212.
46. Sasaki M., Shibata E., Tohyama K., Takahashi J., Otsuka K., Tsuchiya K., Takahashi S., Ehara S., Terayama Y., Sakai A. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Neuroreport 2006, 17:1215-1218.
47. Saunders N.L., Summers M.J. Longitudinal deficits to attention, executive, and working memory in subtypes of mild cognitive impairment. Neuropsychology 2011, 25(2):237-248.
48. Shepherd T.M., Thelwall P.E., Stanisz G.J., Blackband S.J. Aldehyde fixative solutions alter the water relaxation and diffusion properties of nervous tissue. Magn. Reson. Med. 2009, 62:26-34.
49. Shibata E., Sasaki M., Tohyama K., Kanbara Y., Otsuka K., Ehara S., Sakai A. Age-related changes in locus ceruleus on neuromelanin magnetic resonance imaging at 3 Tesla. Magn. Reson. Med. Sci. 2006, 5:197-200.
50. Smith B.R., Johnson G.A., Groman E.V., Linney E. Magnetic resonance microscopy of mouse embryos. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:3530-3533.
51. Takahashi J., Shibata T., Sasaki M., Kudo M., Yanezawa H., Obara S., Kudo K., Ito K., Yamashita F., Terayama Y. Detection of changes in the locus coeruleus in patients with mild cognitive impairment and Alzheimer's disease: high-resolution fast spin-echo T1-weighted imaging. Geriatr. Gerontol. Int. 2015, (in press). 10.1111/ggi.12280.
52. Tovi M., Ericsson A. Measurements of T1 and T2 over time in formalin-fixed human whole-brain specimens. Acta Radiol. 1992, 33:400-404.
53. Vazey E.M., Aston-Jones G. The emerging role of norepinephrine in cognitive dysfunctions of Parkinson's disease. Front. Behav. Neurosci. 2012, 6:48.
54. Vazey E.M., Aston-Jones G. Designer receptor manipulations reveal a role of the locus coeruleus noradrenergic system in isoflurane general anesthesia. Proc. Natl. Acad. Sci. U. S. A. 2014, 111(10):3859-3864.
55. Wilson R.S., Nag S., Boyle P.A., Hizel L.P., Yu L., Buchman A.S., Schneider J.A., Bennett D.A. Neural reserve, neuronal density in the locus ceruleus, and cognitive decline. Neurology 2013, 80(13):1202-1208.
56. Zarow C., Lyness S., Mortimer J., Chui H.C. Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch. Neurol. 2003, 60:337-341.
57. Zecca L., Stroppolo A., Gatti A., Tampellini D., Toscani M., Gallorini M., Giaveri G., Arosio P., Santambrogio P., Fariello R.G., Karatekin E., Kleinman M.H., Turro N., Hornykiewicz O., Zucca F. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:9843-9848.
58. Zecca L.M., Zucca F.A.P., Albertini A.M., Rizzio E.P., Fariello R.G.M. A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease. Neurology 2006, 67(7 Suppl. 2):S8-S11.
59. Zucca F., Bellei C., Giannelli S., Terreni M.R., Gallorini M., Rizzio E., Pezzoli G., Albertini A., Zecca L. Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability. J. Neural Transm. 2006, 113:757-767.